Filter
430
Filtered Results: 430
Text search:
M.
Schwarz
Featured
Recommendations
49
New Publications
78
Language
Document type
No document type
185
Studies & Reports
100
Guidelines
87
Manuals
25
Fact sheets
15
Strategic & Response Plan
11
Training Material
4
Resource Platforms
2
Situation Updates
1
Countries / Regions
Germany
30
Global
21
Western and Central Europe
16
Brazil
13
Russia
13
Latin America and the Carribbean
9
India
8
Syria
7
Eastern Europe
7
Sierra Leone
6
Mozambique
6
Malawi
5
USA
5
South Africa
5
Myanmar / Burma
5
Nepal
4
Nigeria
4
Middle East and North Africa
4
Liberia
4
Kenya
3
Ukraine
3
Benin
3
Guinea
3
Eastern Europe and Central Asia
3
North America
3
Spain
3
Vietnam
3
Indonesia
3
Colombia
2
Rwanda
2
Cameroon
2
Canada
2
Philippines
2
Africa
2
Asia
2
Guinea-Bissau
2
Venezuela
2
Bangladesh
2
Uganda
2
Yemen
2
Ethiopia
2
Angola
2
Iraq
2
Ecuador
2
North Macedonia
1
Tajikistan
1
Turkey
1
Ghana
1
Kyrgyzstan
1
Congo-Brazzaville
1
Burkina Faso
1
Peru
1
Mongolia
1
Italy
1
Armenia
1
Haiti
1
Cambodia
1
Tanzania
1
Congo, Democratic Republic of
1
Paraguay
1
Belgium
1
France
1
United Kingdom
1
Portugal
1
Belarus
1
Southern Africa
1
Argentina
1
Sudan
1
Georgia
1
Chad
1
Botswana
1
South Sudan
1
Authors & Publishers
Publication Years
Category
Countries
115
Clinical Guidelines
51
Public Health
25
Women & Child Health
22
Key Resources
5
Pharmacy & Technologies
5
Capacity Building
1
Toolboxes
COVID-19
81
HIV
47
Mental Health
41
Refugee
31
TB
23
Planetary Health
22
NCDs
16
AMR
14
NTDs
13
Rapid Response
11
Ebola
10
Disability
7
Specific Hazards
6
Caregiver
6
Pharmacy
6
Global Health Education
6
Conflict
5
Zika
5
Social Ethics
3
Natural Hazards
1
Health Financing Toolbox
1
Polio
1
orientations provisoires, première publication : 8 janvier 2021, mise à jour : 15 juin 2021, mise à jour : 19 novembre 2021, mise à jour : 21 janvier 2022
These WHO interim recommendations on the use of the Astra Zeneca – Oxford University AZD1222 vaccine against Covid-19 were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenc...
Antimicrobial resistance (AMR) surveillance plays an important role in the early detection of resistant strains of public health importance and prompt response to outbreaks in hospitals and the community. Surveillance findings are needed to inform medical practice, antibiotic stewardship, and policy...
La vigilancia de la resistencia a los antimicrobianos (RAM) desempeña un papel importante en la detección temprana de cepas resistentes que revisten gran importancia para la salud pública, así como en la respuesta rápida a los brotes en los hospitales y en la comunidad. Los resultados de la vig...
Bei der Publikation von Refugio Stuttgart handelt es sich um eine Bestandsaufnahme und Bedarfsanalyse zur Sprachmittlung im Gesundheitswesen. Beleuchtet werden Grundsätze der psychiatrisch-psychotherapeutischen Versorgung von Geflüchteten, der Einsatz von Sprachmittler*innen durch verschiedene Akt...
This guidance document provides basic principles for a spokesperson of any health authority on how to respond to vocal vaccine deniers. The suggestions are based on psychological research on persuasion, on research in public health, communication studies and on WHO risk communication guidelines.
When situations occur in which unwanted events are rightly or wrongly connected with vaccination, they may erode confidence in vaccines and the authorities delivering them. This document presents the scientific evidence behind WHO’s recommendations on building and restoring confidence in vaccines ...
3 March 2022
The WHO Therapeutics and COVID-19: living guideline contains the Organization’s most up-to-date recommendations for the use of therapeutics in the treatment of COVID-19. The latest version of this living guideline is available in pdf format (via the ‘Download’ button) and via an ...
orientations provisoires, première publication: 10 février 2021, mise à jour : 21 avril 2021, dernière mise à jour : 30 juillet 2021
временное руководство. Первый выпуск: 10 февраля 2021 г. Обновлено: 21 апреля 2021 г. Последнее обновление 30 июля 2021г.
Esta orientação provisória foi desenvolvida com base na recomendação emitida pelo Grupo Consultivo Estratégico de Especialistas (SAGE) em imunização, em sua reunião extraordinária de 5 de janeiro de 2021, e atualizada durante sua reunião extraordinária de 27 de maio de 2021 (2), sendo no...
Overview
16 Dec 2021. This interim guidance pertains to heterologous primary and heterologous boosting schedules of Covid-19 vaccines. It focuses on heterologous schedules combining multiple vaccine platforms (e.g. a vectored vaccine followed by an mRNA vaccine).
Interim recommendations for the use of ChAdOx1-S [recombinant] COVID-19 vaccine (AstraZeneca COVID-19 AZD1222 Vaxzevria™, SII COVISHIELD™ vaccine) - Last updated 30 July 2021
O SAGE aplica os princípios da medicina baseada em evidências e estabeleceu um processo metodológico completo para emitir ou atualizar recomendações. Especificamente para vacinas contra a COVID-19, uma descrição detalhada dos processos metodológicos pode ser encontrada no esquema de evidênc...
Ein Leitfaden für die Zusammenarbeit mit Dolmetscher_innen in Frauenhäusern und mit Fachberatungsstellen
Updated recommendations on treatment of adolescents and children with chronic HCV infection
recommended
The new treatment recommendations that extend the 2018 treat all recommendation for adults with chronic HCV infection to include adolescents and children down to 3 years, and to align the existing recommended pangenotypic direct-acting antiviral (DAA) regimens (SOF/DCV, SOF/VEL and G/P) for adults, ...
